Bhor, M., Li, X., Favret, A., Morrow, P. K. H., Denduluri, N., Barron, R. L., … Lyman, G. H. (2014). Dose delays, dose reductions, and relative dose intensity in patients with cancer who received (neo)adjuvant chemotherapy in community oncology practices. In Journal of Clinical Oncology (Vol. 32, pp. 9606–9606). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2014.32.15_suppl.9606

Bhor, Menaka, Xiaoyan Li, Anne Favret, Phuong Khanh H. Morrow, Neelima Denduluri, Richard L. Barron, Shanmugapriya Saravanan, et al. “Dose delays, dose reductions, and relative dose intensity in patients with cancer who received (neo)adjuvant chemotherapy in community oncology practices.” In Journal of Clinical Oncology, 32:9606–9606. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.9606.

Bhor M, Li X, Favret A, Morrow PKH, Denduluri N, Barron RL, et al. Dose delays, dose reductions, and relative dose intensity in patients with cancer who received (neo)adjuvant chemotherapy in community oncology practices. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 9606–9606.

Bhor, Menaka, et al. “Dose delays, dose reductions, and relative dose intensity in patients with cancer who received (neo)adjuvant chemotherapy in community oncology practices.” Journal of Clinical Oncology, vol. 32, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2014, pp. 9606–9606. Crossref, doi:10.1200/jco.2014.32.15_suppl.9606.

Bhor M, Li X, Favret A, Morrow PKH, Denduluri N, Barron RL, Saravanan S, Girardi V, Patt DA, Li Y, Lyman GH. Dose delays, dose reductions, and relative dose intensity in patients with cancer who received (neo)adjuvant chemotherapy in community oncology practices. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 9606–9606.